Powder: -20°C for 3 years | In solvent: -80°C for 1 year
WS6 是一种具有促beta 细胞增生作用的新型小分子,在啮齿类动物和人源原发性胰岛中EC50值为0.28uM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 239 | 现货 | ||
2 mg | ¥ 333 | 现货 | ||
5 mg | ¥ 496 | 现货 | ||
10 mg | ¥ 795 | 现货 | ||
25 mg | ¥ 1,480 | 现货 | ||
50 mg | ¥ 2,380 | 现货 | ||
100 mg | ¥ 3,530 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 619 | 现货 |
产品描述 | WS6, a β cell proliferation inducer, regulates Erb3 binding protein-1 (EBP1) and the IκB kinase pathway. |
靶点活性 | Proliferation (β cells):0.28 μM |
体外活性 | 在切除β细胞的RIP-DTA小鼠模型中,给口服WS6(50 mg/kg )能够β细胞增殖,从而改善糖尿病. |
体内活性 | 在R7T1细胞中(EC50=0.28 μM),WS6通过Erb3结合蛋白-1和IκB激酶信号通路作用,诱导细胞增殖。 |
激酶实验 | PARP assays are conducted in a buffer containing 50 mM Tris (pH 8.0), 1 mM DTT, 1.5 μM [3H]NAD+?(1.6 μCi/mmol), 200 nM biotinylated histone H1, 200 nM slDNA, and 1 nM PARP-1 or 4 nM PARP-2 enzyme. Reactions are terminated with 1.5 mM benzamide, transferred to streptavidin Flash plates, and counted using a TopCount microplate scintillation counter. |
细胞实验 | R7T1 cells are growth-arrested by removal of doxycycline for 2 days and plated into 384-well plates at a density of 3,000 cells/well in growth medium. Β cell proliferation is assessed using CellTiter Glo after 4 days. Fold increase in cell number is calculated by normalizing compound-treated wells to the median of DMSO-treated wells. (Only for Reference) |
分子量 | 568.59 |
分子式 | C29H31F3N6O3 |
CAS No. | 1421227-53-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (163.6 mM)
Ethanol: 93 mg/mL (163.6 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 1.7587 mL | 8.7937 mL | 17.5874 mL | 43.9684 mL |
5 mM | 0.3517 mL | 1.7587 mL | 3.5175 mL | 8.7937 mL | |
10 mM | 0.1759 mL | 0.8794 mL | 1.7587 mL | 4.3968 mL | |
20 mM | 0.0879 mL | 0.4397 mL | 0.8794 mL | 2.1984 mL | |
50 mM | 0.0352 mL | 0.1759 mL | 0.3517 mL | 0.8794 mL | |
100 mM | 0.0176 mL | 0.0879 mL | 0.1759 mL | 0.4397 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
WS6 1421227-53-3 Angiogenesis JAK/STAT signaling NF-Κb Tyrosine Kinase/Adaptors EGFR IκB/IKK inhibit Inhibitor WS 6 WS-6 inhibitor